Clinical Trial Update: A Study to Learn About Recifercept in Patients With Achondroplasia

View source ↗

Summary

Pfizer completed a clinical trial evaluating Recifercept in achondroplasia. Results from the study were posted on ClinicalTrials.gov in September 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• Recifercept

Snippet

Sponsor: Pfizer | Conditions: Achondroplasia | Status: COMPLETED | Results posted: 2024-09-20